Monday, 2 March 2026
  
Login

Australia's most trusted
source of pharma news

Monday, 02 March 2026
News

10 pharmas win March PBS listings

Posted 2 March 2026 AM

Ten companies have won March PBS listings, with some even securing subsidy for more than one drug.

Roche’s Columvi has made its debut on the scheme after securing the PBAC’s recommendation in July 2025 for use in combination with gemcitabine and oxaliplatin for patients with relapsed or refractory diffuse large B-cell lymphoma who have received one or more lines of systemic therapy and are unable to receive autologous stem cell transplant or CAR-T cell therapy.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (2)

Sales & Customer Relations (10)

Clinical & Medical, R&D (5)

Regulatory, Pharmacovigilance & QA (5)

Devices (1)

Other (17)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.